| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 07/09/2009 | US20090175795 Chimeric therapeutic agents |
| 07/08/2009 | EP2077279A1 Thymic stromal lymphopoietin receptor molecules and uses thereof |
| 07/08/2009 | EP2076544A1 Anti-obese immunogenic hybrid polypeptides and anti-obese vaccine composition comprising the same |
| 07/08/2009 | EP1371730B1 Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |
| 07/08/2009 | EP1232175B1 Method of forming a peptide-receptor complex with zsig33 polypeptides. |
| 07/08/2009 | EP1114172B1 Transfer method for specific cellular localisation of nucleic acids |
| 07/08/2009 | CN101475644A Novel targeted fusion protein with anti-inflammatory action and use thereof |
| 07/08/2009 | CN101475643A Double single chain antibody strengthened fusion protein dFv-LDP-AE, preparation and use thereof |
| 07/08/2009 | CN101475642A AIDS virus recombinant antigen and fusion protein thereof |
| 07/08/2009 | CN101475641A Adenovirus vector avian influenza recombinant vaccine |
| 07/08/2009 | CN100510068C A soluble complex comprising a retroviral surface glycoprotein |
| 07/07/2009 | US7556965 Structural protein of adeno-associated virus with modified antigenicity, its production and its use |
| 07/07/2009 | US7556941 Comprises fusion protein comprising platelet derived growth factor for treating connective tissue, tumor and bone disorders; used to stimulate the production of bone and/or connective tissue in both humans and non-human animals |
| 07/07/2009 | US7556940 Assembly of wild-type and chimeric influenza virus-like particles (VLPs) |
| 07/07/2009 | CA2304255C Hepatitis b virus polypeptides |
| 07/07/2009 | CA2286098C Compositions comprising conjugates of stable, active, human ob protein with antibody fc chain and methods |
| 07/03/2009 | CA2648406A1 Translocator component derivatives and uses thereof |
| 07/02/2009 | WO2009080816A1 Fusion polypeptides comprising a shbg dimerization component and uses thereof |
| 07/02/2009 | WO2009080254A1 Bivalent, bispecific antibodies |
| 07/02/2009 | WO2009080253A1 Bivalent, bispecific antibodies |
| 07/02/2009 | WO2009080252A1 Bivalent, bispecific antibodies |
| 07/02/2009 | WO2009080251A1 Bivalent, bispecific antibodies |
| 07/02/2009 | WO2009079796A1 Recombinant rsv antigens |
| 07/02/2009 | WO2009041830A3 Cell-permeabilising peptides and polypeptides for microbial cells |
| 07/02/2009 | WO2008142198A3 A method for inhibiting or stimulating angiogenesis in an individual |
| 07/02/2009 | US20090170191 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer |
| 07/02/2009 | US20090169578 Tolerizing agents |
| 07/02/2009 | US20090169574 Heteroclitic analogs and related methods |
| 07/02/2009 | CA2710600A1 Recombinant rsv antigens |
| 07/02/2009 | CA2709430A1 Bivalent, bispecific antibodies |
| 07/02/2009 | CA2709347A1 Bivalent, bispecific antibodies |
| 07/02/2009 | CA2709345A1 Bivalent, bispecific antibodies |
| 07/02/2009 | CA2709023A1 Bivalent, bispecific antibodies |
| 07/01/2009 | EP2075336A1 Purification of recombinant proteins fused to multiple epitopes |
| 07/01/2009 | EP2075335A2 Methods and compositions for inhibiting neoplastic cell growth |
| 07/01/2009 | EP2075258A1 Antibody against rgd in amino acid sequence of extracellular matrix protein and production method and use of the same |
| 07/01/2009 | EP2075256A2 Multispecific binding molecules |
| 07/01/2009 | EP2074138A1 Neuroprotective peptide inhibitors of ap-1 signaling and uses therefor |
| 07/01/2009 | EP2073850A1 Hybrid block copolymer micelles with mixed stereochemistry for encapsulation of hydrophobic agents |
| 07/01/2009 | EP1527100B1 Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same |
| 07/01/2009 | EP1351967B1 Compositions and methods for the therapy and diagnosis of lung cancer |
| 07/01/2009 | EP1124846B1 Nucleotide and protein sequences of nogo genes and methods based thereon |
| 07/01/2009 | EP1104310B1 Expression and characterization of hiv-1 envelope protein associated with a broadly reactive neutralizing antibody response |
| 07/01/2009 | CN101469329A Compositions and methods for increasing bone mineralization |
| 07/01/2009 | CN101469031A High cell toxicity targeting fusion protein |
| 07/01/2009 | CN101469030A Interleukin 2-interleukin 23 fusion protein, and preparation and use thereof |
| 07/01/2009 | CN101469029A Interleukin 23-interleukin 6 fusion protein and preparation |
| 07/01/2009 | CN101469028A Use of tumor necrosis factor receptor-immunoglobulin fusion protein for lung cancer pharmaceutical |
| 07/01/2009 | CN101469027A Calprotectin-blood platelet factor-4 fusion protein and use |
| 07/01/2009 | CN101469026A Human epidermal growth factor receptor-blood platelet factor-4 fusion protein and use |
| 07/01/2009 | CN101469025A Human epidermal growth factor receptor specific fusion protein and use |
| 07/01/2009 | CN101469024A Calreticulin- VEGFR2 fusion protein and use |
| 07/01/2009 | CN101469023A Tumor necrosis factor-immunoglobulin fusion protein for lymphoid tumor medicament |
| 07/01/2009 | CN101469022A Human epidermal growth factor receptor specific fusion protein |
| 07/01/2009 | CN101469021A HEGF and IL-23 recombination and use |
| 07/01/2009 | CN100506845C IFNAR2 mutants, their production and use |
| 06/30/2009 | US7553494 WT1 fusion proteins |
| 06/30/2009 | CA2161445C Immunogenic lhrh peptide constructs and synthetic universal immune stimulators for vaccines |
| 06/25/2009 | WO2009079564A2 Immunogenic compositions and methods of use thereof |
| 06/25/2009 | WO2009079242A2 Aglycosylated immunoglobulin mutants |
| 06/25/2009 | WO2009079053A2 High affinity metal-oxide binding peptides with reversible binding |
| 06/25/2009 | WO2009078438A1 Microbe complex |
| 06/25/2009 | WO2009077569A1 Biokinetics of fast-clearing polypeptides |
| 06/25/2009 | WO2009077436A2 Method for preparing protein conjugates |
| 06/25/2009 | US20090163411 Long acting vegf inhibitors and methods of use |
| 06/25/2009 | US20090162367 Nucleotide and protein sequences of Nogo genes and methods based thereon |
| 06/25/2009 | US20090162284 Anti-igf-i receptor antibody |
| 06/24/2009 | EP2072527A1 Fusion polypeptides comprising a SHBG dimerization component and uses thereof |
| 06/24/2009 | CN101466738A Vaccine carrier |
| 06/24/2009 | CN101463090A Fusion protein of fibronectin and cadherin-11, preparation and use thereof |
| 06/24/2009 | CN101463089A Human serum albumin-interferon fusion protein, and encoding gene and use thereof |
| 06/24/2009 | CN100503640C Anti tumour fusion protein and its coding gene and application |
| 06/23/2009 | US7550563 Method for the purification of a non-immunoglobulin protein comprising an immunoglobulin-like (Ig-like) domain |
| 06/23/2009 | US7550432 Recombinant fusion proteins to growth hormone and serum albumin |
| 06/23/2009 | US7550280 Lipases and uses thereof |
| 06/23/2009 | CA2173822C Cytoplasmic expression of antibodies, antibody fragments and antibody fragment fusion molecules in e. coli |
| 06/18/2009 | WO2009076426A1 Engineering zymogen for conditional toxicity |
| 06/18/2009 | WO2009073977A1 Polypeptides modified by protein trans-splicing technology |
| 06/18/2009 | WO2007137329A3 Multi-gene expression vehicle |
| 06/18/2009 | WO2007109749A8 Methods for preventing and treating amyloidogenic diseases |
| 06/18/2009 | WO2004024077A3 Novel composition and methods for the treatment of psoriasis |
| 06/18/2009 | US20090156495 Compositions and methods for modulating immune responses |
| 06/18/2009 | US20090155912 Method for transfer of molecular substances with prokaryontic nucleic acid-binding proteins |
| 06/18/2009 | US20090155897 Glycoprotein vi fusion proteins |
| 06/18/2009 | US20090155845 Molecules designated LDCAM |
| 06/18/2009 | US20090155810 Methods for producing members of specific binding pairs |
| 06/18/2009 | US20090155350 Chlamydia antigens and protein vaccine |
| 06/18/2009 | US20090155302 Antigen Arrays for Treatment of Allergic Eosinophilic Diseases |
| 06/18/2009 | US20090155268 Growth Factor Binding Constructs Materials and Methods |
| 06/18/2009 | US20090155264 Novel composition and methods for the treatment of psoriasis |
| 06/18/2009 | US20090155263 Compositions and methods for the treatment of immune related diseases |
| 06/18/2009 | US20090155165 Anti-igf-i receptor antibody |
| 06/18/2009 | CA2708609A1 Engineering zymogen for conditional toxicity |
| 06/18/2009 | CA2707979A1 Polypeptides modified by protein trans-splicing technology |
| 06/17/2009 | EP2070949A2 Gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 06/17/2009 | EP2070944A1 Specific binding agents of human angiopoietin-2 |
| 06/17/2009 | EP1745078B1 Method for the purification of albumin conjugates |
| 06/17/2009 | EP1015496B1 Divalent anti-t cells immunotoxins and use thereof |
| 06/17/2009 | CN101456913A Anti-tumor fusion protein and use thereof |
| 06/17/2009 | CN100500853C Fusion protein for secretion of protein of interest in supernatant of bacterial culture |